Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt

Cancers (Basel). 2023 Sep 30;15(19):4817. doi: 10.3390/cancers15194817.

Abstract

Gestational trophoblastic neoplasia (GTN) includes several rare malignant diseases occurring after pregnancy: invasive moles, choriocarcinoma, placental site trophoblastic tumours, and epithelioid trophoblastic tumours. Multidisciplinary protocols including multi-agent chemotherapy, surgery, and occasionally radiotherapy achieve good outcomes for some high-risk metastatic patients. In this narrative review of the published studies on the topic, we have tried to identify the role of radiotherapy. The available studies are mainly small, old, and retrospective, with incomplete data regarding radiotherapy protocols delivering low doses (which can make this disease appear radioresistant in some cases despite high response rates with palliative doses) to wide fields (whole-brain, whole-liver, etc.), which can increase toxicity. Studies considering modern techniques are needed to overcome these limitations and determine the full potential of radiotherapy beyond its antihemorrhagic and palliative roles.

Keywords: gestational trophoblastic neoplasia; radiation; radiotherapy; rare cancer.

Publication types

  • Review

Grants and funding

The authors declare that they have no funding and no financial support.